Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCE-MRI-based Dose Escalation in Poor-prognosis Head and Neck Cancer
NCT02031250Phase 2Completed
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Feb 2014
- Primary completion
- Feb 2023
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in squamous cell carcinoma of the head and neck (HNSCC), sponsored by University of Michigan Rogel Cancer Center. Started Feb 2014; status: completed.
02
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT02031250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02031250.